Viatris Inc. (VTRS)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS92556V1061
20.67 USD
-1.85% today Updated 12 Nov 2026 21:00
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Viatris Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:00. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 08:00 · estimate 0.61
Last results
0.71 vs 0.64 estimated
05 Nov 2026 · Beat +11.3%
Beat the estimate
9 of 12
2 missed · 1 in line · 7 beats in a row
Average surprise
+6.3%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 0.61 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 0.64 | 0.71 | +11.3% | Beat |
| 06 Aug 2026 06:00 | 0.60 | 0.69 | +15.0% | Beat |
| 07 May 2026 06:00 | 0.50 | 0.59 | +17.5% | Beat |
| 26 Feb 2026 06:00 | 0.53 | 0.57 | +7.4% | Beat |
| 06 Nov 2025 06:00 | 0.62 | 0.67 | +8.5% | Beat |
| 07 Aug 2025 06:00 | 0.56 | 0.62 | +11.6% | Beat |
| 08 May 2025 07:00 | 0.49 | 0.50 | +1.6% | Beat |
| 27 Feb 2025 06:00 | 0.57 | 0.54 | -5.6% | Miss |
| 07 Nov 2024 07:00 | 0.68 | 0.75 | +10.7% | Beat |
| 08 Aug 2024 06:00 | 0.68 | 0.69 | +2.3% | Beat |
| 09 May 2024 06:00 | 0.67 | 0.67 | -0.4% | In line |
| 28 Feb 2024 06:00 | 0.65 | 0.62 | -4.3% | Miss |
| 07 Nov 2023 16:00 | 0.74 | 0.79 | +6.8% | Beat |
| 07 Aug 2023 06:00 | 0.71 | 0.75 | +5.4% | Beat |
| 08 May 2023 06:00 | 0.70 | 0.77 | +10.6% | Beat |
| 27 Feb 2023 06:00 | 0.72 | 0.67 | -6.1% | Miss |
| 07 Nov 2022 06:00 | 0.84 | 0.87 | +4.3% | Beat |
| 08 Aug 2022 06:00 | 0.82 | 0.88 | +7.1% | Beat |
| 09 May 2022 06:00 | 0.83 | 0.93 | +12.3% | Beat |
| 28 Feb 2022 06:00 | 0.83 | 0.80 | -3.0% | Miss |
| 08 Nov 2021 06:00 | 0.88 | 0.99 | +11.9% | Beat |
| 09 Aug 2021 06:00 | 0.88 | 0.98 | +11.1% | Beat |
| 10 May 2021 06:00 | 0.80 | 0.92 | +15.7% | Beat |
| 01 Mar 2021 17:00 | 1.24 | 0.62 | -50.3% | Miss |
| 06 Nov 2020 09:00 | 1.16 | 1.31 | +13.1% | Beat |
| 06 Aug 2020 06:00 | 0.98 | 1.11 | +13.2% | Beat |
| 11 May 2020 08:00 | 0.87 | 0.90 | +4.6% | Beat |
| 27 Feb 2020 16:00 | 1.28 | 1.40 | +9.2% | Beat |
| 05 Nov 2019 07:00 | 1.14 | 1.17 | +3.0% | Beat |
| 29 Jul 2019 06:00 | 0.95 | 1.03 | +8.8% | Beat |
| 07 May 2019 08:00 | 0.80 | 0.82 | +2.7% | Beat |
| 26 Feb 2019 16:00 | 1.36 | 1.30 | -4.4% | Miss |
| 05 Nov 2018 16:00 | 1.19 | 1.25 | +5.4% | Beat |
| 08 Aug 2018 08:00 | 1.22 | 1.07 | -12.4% | Miss |
| 09 May 2018 07:00 | 0.96 | 0.96 | +0.1% | In line |
| 28 Feb 2018 22:00 | 1.41 | 1.43 | +1.7% | Beat |
| 06 Nov 2017 07:00 | 1.20 | 1.10 | -8.4% | Miss |
| 09 Aug 2017 08:00 | 1.16 | 1.10 | -5.0% | Miss |
| 10 May 2017 07:00 | 0.92 | 0.93 | +0.7% | In line |
| 01 Mar 2017 07:00 | 1.42 | 1.57 | +10.5% | Beat |
| 09 Nov 2016 16:00 | 1.45 | 1.38 | -5.0% | Miss |
| 09 Aug 2016 16:00 | 1.13 | 1.16 | +2.6% | Beat |
| 03 May 2016 02:00 | 0.75 | 0.76 | +1.0% | In line |
| 10 Feb 2016 16:00 | 1.28 | 1.22 | -4.4% | Miss |
| 30 Oct 2015 07:00 | 1.37 | 1.43 | +4.0% | Beat |
| 06 Aug 2015 07:00 | 0.91 | 0.91 | -0.1% | In line |
| 05 May 2015 16:00 | 0.70 | 0.70 | -0.6% | In line |
| 02 Mar 2015 16:00 | 1.05 | 1.05 | +0.0% | In line |
| 30 Oct 2014 16:00 | 1.13 | 1.16 | +3.0% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 14.3B | -3.0% | -3.5B | -24.6% | -3.00 | -466.0% | 1.9B |
| 2024 | 14.7B | -4.5% | -634.2M | -4.3% | -0.53 | -1,160.0% | 1.9B |
| 2023 | 15.4B | -5.1% | 54.7M | 0.4% | 0.05 | -97.1% | 2.3B |
| 2022 | 16.3B | — | 2.1B | 12.8% | 1.71 | — | 2.5B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 21.05 | 21.20 | 20.65 | 20.67 | -1.85% | 6,720,086 | |
| 11 Nov 2026 | 20.76 | 21.10 | 20.60 | 21.06 | +1.01% | 14,448,800 | |
| 10 Nov 2026 | 20.41 | 20.86 | 20.26 | 20.85 | +1.76% | 11,179,700 | |
| 09 Nov 2026 | 20.11 | 20.53 | 19.90 | 20.49 | +2.91% | 12,636,200 | |
| 06 Nov 2026 | 18.79 | 19.94 | 18.79 | 19.91 | +4.96% | 14,534,000 | |
| 05 Nov 2026 | 19.43 | 19.96 | 18.79 | 18.97 | -1.30% | 11,921,600 | |
| 04 Nov 2026 | 19.33 | 19.33 | 18.71 | 19.22 | +1.59% | 8,447,400 | |
| 03 Nov 2026 | 18.70 | 18.94 | 18.64 | 18.92 | +1.34% | 7,550,000 | |
| 02 Nov 2026 | 19.06 | 19.12 | 18.65 | 18.67 | -1.94% | 7,246,400 | |
| 30 Oct 2026 | 19.29 | 19.51 | 19.00 | 19.04 | -0.83% | 8,792,500 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Viatris Named to Fortune's World's Best Workplaces™ List for Second Consecutive Year (opens in a new tab) 12 Nov 2026 13:00
- Viatris to Participate in Upcoming Investor Conferences (opens in a new tab) 11 Nov 2026 11:59
- VTRS or DHR: Which Is the Better Value Stock Right Now? (opens in a new tab) Zacks · 10 Nov 2026 19:38
- Viatris Inc. (VTRS) Hit a 52 Week High, Can the Run Continue? (opens in a new tab) Zacks · 10 Nov 2026 13:15
- VTRS Q3 2026 deep dive: new product launches and Pacira acquisition shape outlook (opens in a new tab) StockStory · 10 Nov 2026 08:45
- Viatris (VTRS) Stock May Be Below Fair Value Despite A $1.65B Deal (opens in a new tab) Simply Wall St. · 08 Nov 2026 01:15
- Xeris Biopharma (XERS) Adds Menassie M. Taddese To Its Board (opens in a new tab) Simply Wall St. · 07 Nov 2026 11:13
- Viatris (VTRS) Earnings Beat And Higher Outlook Put Fair Value Back In Focus (opens in a new tab) Simply Wall St. · 07 Nov 2026 09:17
- Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink? (opens in a new tab) Barchart · 06 Nov 2026 12:03
- Viatris Inc (VTRS) (Q3 2026) Earnings Call Highlights: Raised Guidance, Pacira Deal and Supply ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 23:15
- Viatris Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 22:41
- Viatris (VTRS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 21:35
- This Former Mylan/Pfizer Combo Backed Into Its Buy Zone — What You Should Know (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:26
- Here's What Key Metrics Tell Us About Viatris (VTRS) Q3 Earnings (opens in a new tab) Zacks · 05 Nov 2026 18:30
- Viatris Q3 Earnings Beat on Stronger Margins, Revenues Fall Y/Y (opens in a new tab) Zacks · 05 Nov 2026 14:23
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 21.06 USD
- Market cap
- 24.2B
- Dividend yield
- 2.27%
- 5-year average yield
- 3.95%
- Payout ratio
- 960%
- Last dividend
- 0.1200 USD · 23 Nov 2026
- Next ex-dividend date
- 23 Nov 2026
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 21 Aug 2026 | 0.1200 USD |
| 22 May 2026 | 0.1200 USD |
| 09 Mar 2026 | 0.1200 USD |
| 24 Nov 2025 | 0.1200 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow VTRS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.